IM Cannabis Corp. Files 6-K Report

TL;DR

IM Cannabis Corp. filed a routine 6-K, no major news.

AI Summary

IM Cannabis Corp. filed a Form 6-K on May 7, 2025, reporting as a foreign private issuer. The filing does not contain specific financial figures or material events for the month of May 2025, but confirms their ongoing reporting status. The company is incorporated in Israel and its principal executive offices are located in Kibbutz Glil Yam.

Why It Matters

This filing indicates that IM Cannabis Corp. is continuing its reporting obligations as a foreign private issuer with the SEC, which is standard procedure for companies listed on US exchanges but based abroad.

Risk Assessment

Risk Level: low — This is a routine filing confirming reporting status and does not disclose new material information or financial events.

Key Players & Entities

• IM Cannabis Corp. (company) — Registrant
• 001-40065 (dollar_amount) — Commission File Number
• Kibbutz Glil Yam, Central District, Israel (company) — Principal executive offices location

FAQ

From the Filing

0001178913-25-001621.txt : 20250507 0001178913-25-001621.hdr.sgml : 20250507 20250507071755 ACCESSION NUMBER: 0001178913-25-001621 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20250507 FILED AS OF DATE: 20250507 DATE AS OF CHANGE: 20250507 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IM Cannabis Corp. CENTRAL INDEX KEY: 0001792030 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40065 FILM NUMBER: 25919268 BUSINESS ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 BUSINESS PHONE: 416-256-4202 MAIL ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 6-K 1 zk2533126.htm 6-K   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of May 2025   Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executive offices)   Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒      Form 40-F ☐   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____   Note : Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____   Note : Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.   SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.       IM CANNABIS CORP.     (Registrant)         Date: May 7, 2025 By: /s/ Oren Shuster     Name: Oren Shuster     Title: Chief Executive Officer and Director EXHIBIT INDEX   99.1 News Release dated May 7, 2025 EX-99.1 2 exhibit_99-1.htm EXHIBIT 99.1 Exhibit 99.1 IM Cannabis Announces Filing of Information Circular for Upcoming Annual General and Special Meeting and Provides Additional Information on the Focus Transaction   TORONTO and GLIL YAM, Israel, May 7, 2025/CNW/ -- IM Cannabis Corp. (Nasdaq: IMCC) (CSE: IMCC)  (the “ Company ” or “ IM Cannabis ”), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that, further its news release dated April 11, 2025 (the “ April 11 Release ”), it has filed a management information circular (the “ Circular ”) in connection with the upcoming annual general and special meeting of the shareholders of the Company (“ Shareholders ”) to be held on May 23, 2025 (the &#82